2021 FDA Pharmacy Program Director 
The Checkup by Singlecare
JUNE 18, 2024
Trintellix (vortioxetine) is a brand-name prescription medication that’s approved by the Food and Drug Administration (FDA) to treat major depressive disorder (MDD) in adults. A review published in 2021 included data from only 263 people who had discontinued this drug. clinical pharmacy program director at Harbor Health.
The Checkup by Singlecare
JULY 9, 2024
Jardiance (empagliflozin) and Trulicit y (dulaglutide) are brand-name medicines that are approved by the Food and Drug Administration (FDA) for blood sugar control in people with Type 2 diabetes. clinical pharmacy program director at Harbor Health. Beyond that, they are very different prescription medications.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
SEPTEMBER 12, 2023
the clinical pharmacy program director at Harbor Health. According to the FDA, Guillain-Barré syndrome has been reported very rarely after Shingrix. Side effects are most common in older adults, ages 50 to 69. They’re less likely to occur in patients 70 and over, according to Jodie Pepin , Pharm.D.,
The Checkup by Singlecare
OCTOBER 25, 2024
clinical pharmacy program director at Harbor Health. Additionally, the Food and Drug Administration (FDA) prescribing information for Ozempic does not mention blood clots as a possible adverse reaction. “There is not enough evidence to say that semaglutide definitely causes blood clots,” says Jodie Pepin, Pharm.D.
The Checkup by Singlecare
SEPTEMBER 15, 2023
the clinical pharmacy program director at Harbor Health. Mayo Clinic (2021) Adverse events in people taking macrolide antibiotics versus placebo for any indication. Cochrane Library (2019) Clostridium difficile Infection Risk with Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System.
Expert insights. Personalized for you.
104 
Let's personalize your content